Sleep Medicine and Psychophysiology (수면정신생리)

KOREAN ACADEMY OF SLEEP MEDICINE (대한수면의학회)
권호 표지
DOI QR코드

DOI QR Code

Association between Antipsychotic-Induced Restless Legs Syndrome and Glutathione S-Transferase Gst-M1, Gst-T1 and Gst-P1 Gene Polymorphisms

Glutathione S-Transferase (GST) 유전자 다형성과 항정신병약물로 유발된 하지불안증후군의 연관 연구

  • Kang, Seung-Gul (Department of Psychiatry, Gil Medical Center, Gachon University, School of Medicine) ;
  • Park, Young-Min (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine) ;
  • Kim, Leen (Department of Psychiatry, Korea University College of Medicine) ;
  • Lee, Heon-Jeong (Department of Psychiatry, Korea University College of Medicine)
  • 강승걸 (가천대학교 의과대학 길병원 정신건강의학교실) ;
  • 박영민 (인제대학교 의과대학 일산백병원 정신건강의학교실) ;
  • 김린 (고려대학교 의과대학 정신건강의학교실) ;
  • 이헌정 (고려대학교 의과대학 정신건강의학교실)
  • Received : 2015.05.18
  • Accepted : 2015.05.30
  • Published : 2015.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The pathophysiology of restless legs syndrome (RLS) has not been fully elucidated. Oxidative stress might play a role in the development of RLS and other antipsychotic-induced side effects such as tardive dyskinesia. In the present study, we investigated whether the glutathione S-transferase (GST) gene polymorphisms are associated with antipsychotic-induced RLS in schizophrenia. Methods: We assessed antipsychotic-induced RLS symptoms in 190 Korean schizophrenic patients using the diagnostic criteria of the International Restless Legs Syndrome Study Group. The GST-M1, GST-T1 and GST-P1 loci were analyzed using PCR-based methods. Results: We divided the subjects into 2 groups: those with RLS symptoms (n = 96) and those without RLS symptoms (n = 94). There were no significant differences in the distributions of the GST-M1 genotypes (${\chi}^2=3.56$, p = 0.059), GST-T1 (${\chi}^2=0.51$, p = 0.476) and GST-P1 (${\chi}^2=0.57$, p = 0.821) between the 2 groups. Comparison of the RLS score among genotypes of the GST-M1 (t = -1.54, p = 0.125), GST-T1 (t = -0.02, p = 0.985) and GST-P1 (F = 0.58, p = 0.560) revealed no significant difference. Conclusion: These data suggest that GST gene polymorphisms do not confer increased susceptibility to RLS symptoms in schizophrenic patients. Future studies are necessary to evaluate the possible influences of other candidate genes involved in the reactive oxygen species system.

목 적 : 하지불안증후군(restless legs syndrome ; RLS)의 병인은 아직 불명확하지만, 유전적 질환으로 알려져 있다. 산화스트레스는 RLS, 지연성운동장애, 파킨슨병, 뚜렛장애 등의 운동장애에서 주요한 원인 중의 하나로 생각되고 있다. 본 연구에서는 조현병환자에서 항정신병약물에 의해 유발된 RLS 증상이 산화손상의 해독효소인 glutathione S-transferase (GST) 유전자의 다형성과 연관이 있는지를 밝히고자 하였다. 방 법 : International Restless Legs Syndrome Study Group의 진단기준으로 190명의 한국인 조현병 환자들을 대상으로 RLS에 대해서 평가하였다. 유전자형분석은 중합효소연쇄반응기법을 사용하여 GST-M1, GST-T1, GST-P1의 세 가지 단일염기다형성(single nucleotide polymorphism, SNP)에 대해서 시행되었다. 결 과 : RLS 증상군 96명과 무증상군 94명으로 피험자들을 분류하였다. GST-M1 (${\chi}^2=3.56$, p = 0.059), GST-T1 (${\chi}^2=0.51$, p = 0.476), GST-P1 (${\chi}^2=0.57$, p = 0.821)의 유전자형 빈도에 두 군간에 통계적으로 유의한 차이가 없었다. 유전자형에 따른 RLS 척도의 점수도 GST-M1 (t = -1.54, p = 0.125), GST-T1 (t = -0.02, p = 0.985), GST-P1 (F = 0.58, p = 0.560)의 세 가지 SNP에서 통계적으로 유의한 차이를 보이지 않았다. 결 론 : 본 연구의 결과 GST 유전자 다형성이 항정신병약물로 유발된 RLS 증상 발생의 민감성을 증가시킨다는 증거는 발견할 수 없었다. 산화손상과 관련된 다른 후보 유전자들에 대한 향후 연구가 필요할 것으로 사료된다.

Keywords

References

  1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless leg syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 2003;4:101-119. https://doi.org/10.1016/S1389-9457(03)00010-8
  2. Andreassen OA, Jorgensen HA. Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia? Prog Neurobiol 2000;61:525-541. https://doi.org/10.1016/S0301-0082(99)00064-7
  3. Baskol G, Korkmaz S, Erdem F, Caniklioglu A, Kocyigit M, Aksu M. Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome. Sleep Med 2012;13:414-418. https://doi.org/10.1016/j.sleep.2011.11.012
  4. Chen S, Ondo WG, Rao S, Li L, Chen Q, Wang Q. Genomewide linkage scan identifies a novel susceptibility locus for RLS on chromosome 9p. Am J Hum Genet 2004;74:876-889. https://doi.org/10.1086/420772
  5. Cho CH, Kang SG, Choi JE, Park YM, Lee HJ, Kim L. Association between Antipsychotics-Induced Restless Legs Syndrome and Tyrosine Hydroxylase Gene Polymorphism. Psychiatry Investig 2009;6:211-215. https://doi.org/10.4306/pi.2009.6.3.211
  6. Cikrikcioglu MA, Hursitoglu M, Erkal H, Kinas BE, Sztajzel J, Cakirca M, et al. Oxidative stress and autonomic nervous system functions in restless legs syndrome. Eur J Clin Invest 2011;41:734-742. https://doi.org/10.1111/j.1365-2362.2010.02461.x
  7. de Leon J, Susce MT, Pan RM, Koch WH, Wedlund PJ. Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness. J Clin Psychopharmacol 2005;25:448-456. https://doi.org/10.1097/01.jcp.0000177546.34799.af
  8. De Palma G, Mozzoni P, Mutti A, Calzetti S, Negrotti A. Case-control study of interactions between genetic and environmental factors in Parkinson's disease. The Lancet 1998;352:1986-1987. https://doi.org/10.1016/S0140-6736(05)61332-3
  9. Desautels A, Turecki G, Montplaisir J, Ftouhi-Paquin N, Michaud M, Chouinard VA, et al. Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis. Neurology 2001;57:1304-1306. https://doi.org/10.1212/WNL.57.7.1304
  10. Desautels A, Turecki G, Montplaisir J, Xiong L, Walters AS, Ehrenberg BL, et al. Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol 2005;62:591-596. https://doi.org/10.1001/archneur.62.4.591
  11. Han OS, Hong JP. Structured Clinical Interview for DSM-IV Axis I Disorder-Korean Version. Seoul, Hana Medical Publishing;2000.
  12. Jung JS, Lee HJ, Cho CH, Kang SG, Yoon HK, Park YM, et al. Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia. Chronobiol Int 2014;31:838-844. https://doi.org/10.3109/07420528.2014.914034
  13. Kang SG, Lee HJ, Choi JE, Kim L, Jung IK. Association study between dopamine transporter gene 40 bp VNTR and antipsychotics-induced restless legs syndrome. Sleep Med Psychophysiol 2008;15:39-43.
  14. Kang SG, Lee HJ, Choi JE, An H, Rhee M, Kim L. Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia. Hum Psychopharmacol 2009;24:55-60. https://doi.org/10.1002/hup.988
  15. Kang SG, Lee HJ, Choi JE, Park JH, Lee SS, Han C, et al. Possible association between G-protein ${\beta}3$ subunit C825T polymorphism and antipsychotic-induced restless legs syndrome in schizophrenia. Acta Neuropsychiatr 2007;19:351-356. https://doi.org/10.1111/j.1601-5215.2007.00240.x
  16. Kang SG, Lee HJ, Choi JE, Park YM, Park JH, Han C, et al. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia. Neuropsychobiology 2008;57:49-54. https://doi.org/10.1159/000129667
  17. Kang SG, Lee HJ, Jung SW, Cho SN, Han C, Kim YK, et al. Characteristics and clinical correlates of restless legs syndrome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1078-1083. https://doi.org/10.1016/j.pnpbp.2007.03.011
  18. Kang SG, Lee HJ, Lee SH, Kim L. MEIS1, a Promising Candidate Gene, Is Not Associated with the Core Symptoms of Antipsychotic-Induced Restless Legs Syndrome in Korean Schizophrenia Patients. Psychiatry Investig 2015;12:263-267. https://doi.org/10.4306/pi.2015.12.2.263
  19. Kang SG, Lee HJ, Park YM, Yang HJ, Song HM, Lee YJ, et al. The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia. Hum Psychopharmacol 2013;28:117-123. https://doi.org/10.1002/hup.2287
  20. Kang SG, Park YM, Choi JE, Lim SW, Lee HJ, Lee SH, et al. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia. Hum Psychopharmacol 2010;25:397-403. https://doi.org/10.1002/hup.1130
  21. Kemlink D, Plazzi G, Vetrugno R, Provini F, Polo O, Stiasny-Kolster K, et al. Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics 2008;9:75-82. https://doi.org/10.1007/s10048-007-0113-1
  22. Levchenko A, Montplaisir JY, Dube MP, Riviere JB, St-Onge J, Turecki G, et al. The 14q restless legs syndrome locus in the French Canadian population. Ann Neurol 2004;55:887-891. https://doi.org/10.1002/ana.20140
  23. Levchenko A, Provost S, Montplaisir JY, Xiong L, St-Onge J, Thibodeau P, et al. A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. Neurology 2006;67:900-901. https://doi.org/10.1212/01.wnl.0000233991.20410.b6
  24. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-65. https://doi.org/10.1002/mds.870120111
  25. Ondo W, Jankovic J. Restless legs syndrome: Clinicoetiologic correlates. Neurology 1996;47:1435-1441. https://doi.org/10.1212/WNL.47.6.1435
  26. Pichler I, Marroni F, Volpato CB, Gusella JF, Klein C, Casari G, et al. Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate. Am J Hum Genet 2006;79:716-723. https://doi.org/10.1086/507875
  27. Shen CP, Chou IC, Liu HP, Lee CC, Tsai Y, Wu BT, et al. Association of glutathione S-transferase P1 (GSTP1) polymorphism with Tourette syndrome in Taiwanese patients. Genet Test Mol Biomarkers 2014;18:41-44. https://doi.org/10.1089/gtmb.2013.0245
  28. Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix- Trench G. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 2001;22:67-72. https://doi.org/10.1093/carcin/22.1.67
  29. Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007;357:639-647. https://doi.org/10.1056/NEJMoa072743
  30. Walters AS, Hickey K, Maltzman J, Verrico T, Joseph D, Hening W, et al. A questionnaire study of 138 patients with restless legs syndrome: the 'Night-Walkers' survey. Neurology 1996;46:92-95. https://doi.org/10.1212/WNL.46.1.92
  31. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132. https://doi.org/10.1016/S1389-9457(02)00258-7
  32. Wang T, Wang B. Association between Glutathione S-transferase M1/Glutathione S-transferase T1 polymorphisms and Parkinson's disease: a meta-analysis. J Neurol Sci 2014;338:65-70. https://doi.org/10.1016/j.jns.2013.12.018
  33. Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007;39:1000-1006. https://doi.org/10.1038/ng2099
  34. Zhong SL, Zhou SF, Chen X, Chan SY, Chan E, Ng KY, et al. Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese. Eur J Pharm Sci 2006;28:77-85. https://doi.org/10.1016/j.ejps.2006.01.002